Matches in Wikidata for { <http://www.wikidata.org/entity/Q96582045> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q96582045 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96582045 description "scientific article published on 18 June 2020" @default.
- Q96582045 description "wetenschappelijk artikel" @default.
- Q96582045 description "наукова стаття, опублікована 18 червня 2020" @default.
- Q96582045 name "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 name "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 type Item @default.
- Q96582045 label "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 label "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 prefLabel "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 prefLabel "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 P1433 Q96582045-D2C7AFFF-F6BF-4A1D-A9CC-1B3B9137EF5F @default.
- Q96582045 P1476 Q96582045-7F20F410-5715-4F33-9BFE-8239FB010361 @default.
- Q96582045 P2093 Q96582045-1C94AFC1-0BB8-4F02-8E8F-164607943146 @default.
- Q96582045 P2093 Q96582045-38E1C421-78BB-4C75-BB78-11C4519A0FB1 @default.
- Q96582045 P2093 Q96582045-4F5B4DCA-34B1-438A-AE5A-E69745141076 @default.
- Q96582045 P2093 Q96582045-879FF75D-1724-47D0-BC3F-B60EE9A5EAE3 @default.
- Q96582045 P2093 Q96582045-9C89B13E-8BD5-407A-8EE7-572278D2A804 @default.
- Q96582045 P2093 Q96582045-BF42978F-FBCD-4561-BC9A-B6240007A812 @default.
- Q96582045 P2093 Q96582045-D1C423C4-3317-4CA9-AC9A-DB5119A60B6E @default.
- Q96582045 P2093 Q96582045-DD07F84F-7EE5-4CC5-9065-F11A97DD535A @default.
- Q96582045 P2860 Q96582045-3C7C67E0-ECF9-4063-A97A-3C545A1F9429 @default.
- Q96582045 P31 Q96582045-8373A120-E933-437B-AB4D-4FE509669F50 @default.
- Q96582045 P356 Q96582045-23973D05-0572-45A5-8F27-67926ED63797 @default.
- Q96582045 P50 Q96582045-1A1D8784-7DBA-4889-8655-4E3A33DF8A5F @default.
- Q96582045 P50 Q96582045-244D9A77-B55D-444B-940D-40CAD2DE9090 @default.
- Q96582045 P50 Q96582045-C3AEA51B-A196-42A7-B0CD-09CF25EEFF04 @default.
- Q96582045 P577 Q96582045-2E3F17DC-D006-482A-A61A-FA0E098DA852 @default.
- Q96582045 P698 Q96582045-5463CB1C-29E0-4F16-A4E1-08E0F0399A73 @default.
- Q96582045 P921 Q96582045-DEEE2EA9-500C-42E9-BF0E-1982843BE75E @default.
- Q96582045 P356 S10637-020-00966-7 @default.
- Q96582045 P698 32556898 @default.
- Q96582045 P1433 Q2312231 @default.
- Q96582045 P1476 "Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab" @default.
- Q96582045 P2093 "Fumio Imamura" @default.
- Q96582045 P2093 "Hanako Kuhara" @default.
- Q96582045 P2093 "Hayato Kawachi" @default.
- Q96582045 P2093 "Kazumi Nishino" @default.
- Q96582045 P2093 "Kei Kunimasa" @default.
- Q96582045 P2093 "Kika Kuno" @default.
- Q96582045 P2093 "Takako Inoue" @default.
- Q96582045 P2093 "Toru Kumagai" @default.
- Q96582045 P2860 Q27851406 @default.
- Q96582045 P31 Q13442814 @default.
- Q96582045 P356 "10.1007/S10637-020-00966-7" @default.
- Q96582045 P50 Q110571748 @default.
- Q96582045 P50 Q87849771 @default.
- Q96582045 P50 Q98181288 @default.
- Q96582045 P577 "2020-06-18T00:00:00Z" @default.
- Q96582045 P698 "32556898" @default.
- Q96582045 P921 Q413299 @default.